BELLEVUE, Wash. and ZUG, Switzerland, July 8, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced the ...
BASEL, Switzerland, March 25, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for ...
BELLEVUE, Wash., July 31, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovation approaches to health and wellness to support global health ...
Shares of OSR Holdings more than doubled after the company's Vaximm subsidiary announced final data from its Phase 2a clinical trial of VXM01 with avelumab, a drug combination aimed at treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback